Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 14 Aug 2026 for Caris Life Sciences, Inc.. Read the official filing
Filing timeline
BuySaleLloyd Minor
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Lloyd Minor: trading record in brief
Lloyd Minor discloses dealings in 2 companies, chiefly Biogen Inc. and Caris Life Sciences, Inc. Between 17 June 2025 and 14 August 2026, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 2 sales worth €208k. Besides market trades, the filings include 4 share grants. 2026 to date brings no purchases and 2 sales.
On 14 August 2026 came the latest disclosure, a share grant in Caris Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lloyd Minor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
13,192 shares0Common StockSEC:0002038687-26-000007:0
593 shares@ US$200.960.0004% mcap24.9% of flowCommon StockSEC:0000875045-26-000076:1
593 shares@ US$203.340.0004% mcap25.1% of flowCommon StockSEC:0000875045-26-000076:0
1,505 sharesCommon StockSEC:0000875045-26-000054:0
2,492 shares@ US$20.06100.0% of flowCommon StockSEC:0002038687-26-000004:0
2,370 shares0Common StockSEC:0001127602-25-017766:0
6 of 6 declarations
